A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
01/1993
01/05/1993	CA1312328C Derivative of d.25, its preparation process, its use as an immunostimulating agent and pharmaceutical compositions containing such
01/02/1993	CA2072834A1 Ketone derivatives
12/1992
12/30/1992	EP0520834A2 Pharmaceutical composition for treating an immune system disorder comprising PP14 or antibodies against PP14
12/30/1992	EP0520555A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
12/30/1992	EP0520427A1 Cyclopropenone derivatives
12/30/1992	EP0520032A1 Use of spiperone as an immunosuppressant and anti-inflammatory agent
12/30/1992	CN1067427A Pyrazolopyridine compound and processes for preparation thereof
12/29/1992	US5175264 5-[4-(4,6-dimethyl-2-pyrimidinylsulfamoyl)phenylazo]acetylsalicylic acid
12/29/1992	CA2064544A1 Immune cell proliferation inhibitors
12/29/1992	CA1312086C Benzoquinone derivatives, their production and use
12/28/1992	WO1993000106A1 External preparation containing cyclosporin
12/28/1992	CA2090417A1 Topical preparations containing cyclosporin
12/25/1992	CA2071800A1 Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
12/24/1992	DE4120327A1 Neue peptide, ihre herstellung und verwendung New peptides, their preparation and use
12/23/1992	WO1992022662A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992	WO1992022577A1 Immunogen compounds having specifically an anti-cytokine effect, method of preparation, pharmaceutical compositions and kits containing them
12/23/1992	WO1992022569A1 Peptides with tachykinin antagonist activity
12/23/1992	WO1992022565A1 Modified sialyl lewisx compounds
12/23/1992	WO1992022564A1 Immunosuppressive and tolerogenic modified lewisx and lewisa compounds
12/23/1992	WO1992022563A1 Modified sialyl lewisa compounds
12/23/1992	WO1992022553A1 IMIDAZO[1,2-a](PYRROLO, THIENO OR FURANO)[3,2-d]AZEPINE DERIVATIVES, COMPOSITIONS AND METHODS OF USE
12/23/1992	WO1992022551A1 IMIDAZO[2,1-b][3]BENZAZEPINE DERIVATIVES, COMPOSITIONS AND METHOD OF USE
12/23/1992	WO1992022543A1 N-hydroxyurea derivatives which inhibit lipoxygenase
12/23/1992	WO1992022323A1 Intercellular adhesion molecule-3 and its binding ligands
12/23/1992	WO1992022307A1 Remedy for chronic fatigue syndrome
12/23/1992	WO1992022301A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/23/1992	WO1992022294A1 Immunomodulatory azaspiranes
12/23/1992	EP0519866A1 Novel anti-HIV antibodies
12/23/1992	EP0519554A1 Conjugates of the class II protein of the outer membrane of neisseria meningitidis and of HIV-1 related peptides
12/23/1992	EP0519469A1 Cloned glutamic acid decarboxylase
12/23/1992	EP0519449A1 2-Amino-4-aryl thiazoles with antiasthmatic and antiinflammatory activities on the respiratory tract
12/23/1992	EP0519013A1 Peptides stimulating cytotoxic t cells immune to hiv rt
12/23/1992	EP0518872A1 Topical formulation of cyclosporine
12/23/1992	CN1067244A Pyrrolidones
12/23/1992	CN1019576B Preparation of 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-(1) benzothieno (3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides
12/23/1992	CN1019544B Pharmaceutical composition for piperidinoalkanol derivatives
12/23/1992	CA2110997A1 Methods for the synthesis of monofucosylated oligosaccharides terminating in di-n-acetyllactosaminyl structures
12/23/1992	CA2110707A1 Immunosuppressive and tolerogenic oligosaccharide modified lewis x and lewis a compounds
12/23/1992	CA2110577A1 Immunomodulatory azaspiranes
12/23/1992	CA2110495A1 Immunosuppressive and tolerogenic oligosaccharide derivatives
12/23/1992	CA2110387A1 Intercellular adhesion molecule-3 and its binding ligands
12/22/1992	US5173496 Antiinflammatory agents
12/22/1992	CA1311757C Acetylenes disubstituted with a heteroaromatic group and a tetralin group having retinoid like activity
12/22/1992	CA1311754C Thiazole compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
12/20/1992	CA2071088A1 Conjugates of the class ii protein of the outer membrane of neisseria meningitidis and of hiv-1 related peptides, and vaccines containing same
12/20/1992	CA2071066A1 Fk-900520 enzymatic and/or microbial methylation products
12/19/1992	CA2071305A1 Anti-hiv antibodies
12/16/1992	EP0518819A2 Amidino compounds, their manufacture and use as medicament
12/16/1992	EP0518818A2 Arylethers, their manufacture and use as medicament
12/16/1992	EP0518722A1 Dithiane substituted retinoides, their use, process of their preparation, cosmetic and pharmaceutical compositions containing them and their use in therapeutics
12/16/1992	EP0518443A1 Recombinant proteins of viruses associated with lymphadenopathy syndrome and/or acquired immune deficiency syndrome
12/16/1992	EP0518435A1 Imidazo[2,1-b][3]benzazepine derivatives, compositions and method of use
12/16/1992	EP0518434A1 Imidazo(1,2-a)(pyrrolo, thieno or furano)(3,2-d)azepine derivatives, compositions and methods of use
12/16/1992	EP0518426A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis
12/16/1992	EP0517916A1 Immunosuppressant
12/16/1992	EP0517817A1 Inhibitors of catalytic antibodies
12/16/1992	EP0517810A1 Hybrid compound purification
12/16/1992	CN1067053A Pyrazine derivatives and process for preparing same
12/16/1992	CN1019490B Method for producing 3-(1h-tetrazol-5-yl) thieno 2,3-dlpyrimidin-4(3h)-ones
12/15/1992	US5171841 T-cell suppressor protein
12/15/1992	US5171840 Receptor protein for human B cell stimulatory factor-2
12/15/1992	US5171838 Leu3a binding peptides
12/14/1992	CA2070953A1 Thiopyrano (2,3,4-c,d) indoles as inhibitors of leukotriene biosynthesis
12/12/1992	CA2070796A1 Arylethers, their manufacture and methods of treatment
12/12/1992	CA2070795A1 Amidino compounds, their manufacture and methods of treatment
12/10/1992	WO1992021695A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	WO1992021663A1 Benzimidazole-derived compounds, method for preparing same, and therapeutical and cosmetic uses thereof
12/10/1992	WO1992021367A1 T cell receptor peptides as therapeutics for immune-related disease
12/10/1992	WO1992021335A1 Phospholipids
12/10/1992	WO1992021240A1 Suppressor t-cell hybridoma
12/10/1992	WO1992012996A3 Vaccination and methods against diseases resulting from pathogenic responses by specific t cell populations
12/10/1992	WO1992004359A3 Monosaccharides having anti-proliferation and anti-inflammatory activity, compositions and uses thereof
12/10/1992	CA2110158A1 Vitamin d derivatives comprising a lateral chain expoxide group
12/10/1992	CA2109611A1 Phospholipids
12/10/1992	CA2103046A1 Suppressor t-cell hybridoma
12/09/1992	EP0517589A2 Tachykinin derivatives, their preparation and pharmaceutical compositions containing them
12/09/1992	EP0517464A1 Peptides useful in regulating the immune and nervous systems
12/09/1992	EP0517160A1 Extended-release ophthalmic preparations
12/09/1992	EP0516980A1 Novel 2-mercaptomethylene-tetrahydronaphthalene and indane-2-carboxamide derivatives as enkephalinase inhibitors
12/09/1992	EP0516953A1 Conjugates of liposomes or micro-beads and antibodies specific for T lymphocytes
12/09/1992	EP0516941A1 Pyrazolopyridine compounds and processes for preparation thereof
12/08/1992	US5169840 Diequatorially bound β-1, 4 polyuronates and use of same for cytokine stimulation
12/08/1992	US5169835 Pregancy specific proteins applications
12/05/1992	CA2070331A1 Tachykinin denved peptides and pseudopeptides, process for their preparation and pharmaceutical compositions containing them
12/04/1992	WO1992021366A1 Immunoregulatory and neuroregulatory pentapeptides
12/04/1992	CA2088664A1 Immunoregulatory and neuroregulatory pentapeptides
12/02/1992	EP0516069A1 Leukotriene B4 antagonist
12/02/1992	EP0516034A1 Pharmaceutical compositions with immunosuppresive properties
12/02/1992	EP0515523A1 Use of suramin to treat rheumatologic diseases
12/01/1992	WO1992021341A1 Use of rapamycin prodrugs as immunosuppressant agents
12/01/1992	US5168098 Pyrrolo-pyridine derivatives and therapeutic compositions containing them
12/01/1992	US5168045 Diagnostic systems and methods using polypeptide analogs of apolipoprotein e
12/01/1992	US5167949 Antiallergic
12/01/1992	CA2102116A1 Use of rapamycin prodrugs as immunosuppressant agents
12/01/1992	CA2069667A1 Leukotriene b4 antagonist
11/1992
11/30/1992	CA2069469A1 Bicyclic rapamycins
11/30/1992	CA2069468A1 Rapamycin dimers
11/29/1992	CA2069367A1 Pharmaceutical compositions with immunosuppresive properties
11/26/1992	WO1992021033A1 Determination of motifs of peptides on mhc molecules
11/26/1992	WO1992020823A1 Backbone modified oligonucleotide analogs

1 ... 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 ... 1172